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Abstract 
Background: High-sensitivity C-reactive protein (hs-CRP) is associated with several cardiovascular 
risk factors (CVRF) and with renal function markers. However, these associations have not been 
examined in populations in the African region. We analyzed the distribution of hs-CRP and the 
relationship with a broad set of CVRF, renal markers and carotid intima-media thickness (IMT), in the 
Seychelles (African region). 
Methods: We conducted a survey in the population aged 25-64 years (n=1255, participation rate: 
80.2%). Analyses were restricted to persons of predominantly African descent (n=1011). 
Results: Mean and median hs-CRP serum concentration (mg/l) were 3.1 (SD 7.6) and 1.4 (IQR 0.7-
2.9) in men and 4.5 (SD 6.7) and 2.2 (IQR 1.0-5.4) in women (p <0.001 for difference between men 
and women). hs-CRP was significantly associated with several conventional CVRF, and particularly 
strongly with markers of adiposity. With regards to renal markers, hs-CRP was strongly associated 
with cystatin C and with microalbuminuria but not with creatinine. hs-CRP was not associated with 
IMT. 
Conclusions: Serum concentration of hs-CRP was significantly associated with sex, several CVRF 
and selected renal function markers, which extends similar findings in Europe and in North America to 
a population in the African region. These findings can contribute to guide recommendations for the 
use of hs-CRP in clinical practice in the region.  
 
 
Background 
 
Plasma or serum concentration of high-sensitivity C-reactive protein (hs-CRP), a protein synthesized 
by the liver, is the most widely used biomarker of inflammation. It is well demonstrated that hs-CRP 
plasma concentration is associated with cardiovascular risk factors (CVRF) and with renal function (1-
3). hs-CRP is also strongly associated with cardiovascular disease morbidity and mortality (4-9), but 
this association is generally largely attenuated upon adjustment for CVRF (1).  
Carotid intima-media thickness (IMT) is a marker of atherosclerosis and a good predictor of 
cardiovascular events (10-12). Besides the association between hs-CRP and atherosclerosis or 
cardiovascular disease morbidity and mortality, the role of this marker in subclinical atherosclerosis 
has not been systematically demonstrated (13) and studies evaluating the association between hs-CRP 
and IMT have given conflicting results. In a systematic review of the literature, Baldassare et al. 
(13)found that a majority of studies reported an association between IMT and CRP.  
However, most studies on hs-CRP have been conducted in North American and European populations. 
Although hs-CRP plasma concentration is higher in African than Caucasian persons residing in North 
America (14) and in South African black than white women (15), we are not aware of any population-
based study in the African region that has focused on  the distribution of hs-CRP  and the association 
between hs-CRP and a broad set of CVRF, renal function markers and subclinical atherosclerosis. In 
this study, we examined the distribution of hs-CRP and whether hs-CRP is associated with CVRF, 
renal function markers and subclinical atherosclerosis measured by IMT in an African population of a 
middle-income country. 
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Materials and Methods 
 
The Republic of Seychelles consists of over 100 islands located in the Indian Ocean, east to Kenya, in 
the African region. Around 90% of the population lives on the main island. The large majority of the 
population is of African descent. The GDP per capita has increased, in real values, from US$ 2927 in 
1980 to US$ 5239 in 2004. A high prevalence of the main CVRF has been reported (16;17), with 
downward secular trends in smoking and blood pressure and upward trends in overweight and diabetes 
between 1989 and 2004 (18). 
Sampling frame of the survey 
A population-based survey of CVRF was conducted in 2004 (Seychelles Heart Study III) including 
1255 participants (participation rate of 80.2%). The sampling frame, methods and main results have 
been described previously (17). Briefly, a sex- and age-stratified random sample of all inhabitants 
aged 25-64 years was used based on computerized national census data. Participants were free to 
participate and all gave informed consent. The survey was approved by the Ministry of Health after 
technical and ethical reviews. The study protocol conformed to the ethical guideline of the 1975 
Declaration of Helsinki as reflected in a a priori institution ‘s human research committee.  
Measurement of lifestyle-related and clinical variables 
Methods used to assess CVRF have been described previously (17;18). Trained survey officers 
administered a structured questionnaire to the participants. Current cigarette smoking was defined as 
smoking at least one cigarette per day. Mean daily alcohol intake was quantified in the participants 
reporting to drink at least once a month. Alcohol consumption was assessed by questions on drinking 
frequency and volume for the main available alcoholic beverages and mean daily ethanol intake was 
calculated. Participants were asked about their current occupation or, if not currently employed, about 
their occupation when they were last employed. Three categories were considered in this study: 
“laborer” (manual occupation with no formal training), “professional” (which included non-manual 
occupations with formal training such as teachers, nurses) and “intermediate” (all other categories). . 
Weight and height were measured and body mass index (BMI) calculated as weight (kg) divided by 
height (m) squared. Waist circumference (waist) was measured at the level of the umbilicus in the 
standing position, with individuals in light garments. Body fat mass was measured using a noninvasive 
bioimpedance analyzer (Omron body fat monitor HBF-300). Blood pressure was defined as the 
average of the two last of three measurements, taken at intervals of at least 2 minutes, using a mercury 
sphygmomanometer, after participants had been seated for at least 30 minutes.  
Measurement of biochemical variables 
Eligible participants were requested to be fasting since midnight. A blood sample was taken in the 
morning, centrifuged within 2 hours and serum was immediately frozen at -20°C. Fasting plasma 
glucose was measured with a point-of-care analyzer (Cholestec LDX, Hayward, USA). For values 
≥5.6 mmol/l in persons not known to have diabetes, an additional capillary measurement was 
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performed within 10 minutes with an Ascensia Elite glucometer, which adjusts values to plasma 
values, and the mean value of the two measures was considered, as described previously (19). 
Diabetes was defined as a fasting blood glucose ≥7.0 mmol/l or a personal history of current diabetes 
treatment (20). Except for glucose, all blood analyses were performed at the Canton Laboratory for 
Biochemistry and Hematology, St Gallen, Switzerland using standard techniques. LDL-cholesterol 
was calculated with the Friedewald formula. hs-CRP was measured by using a latex-enforced 
immunonephelometry using the BN II (Dade Behring) method. Of note, there is no cross-reactivity or 
interference known with the hs-CRP method, which we used. Microalbuminuria was assessed on the 
second morning urine collected at the study center using a semi-quantitative method (Clinitek Status, 
Bayer), as described before (21). Serum cystatin C was measured by means of a particle-enhanced 
immunonephelometric assay with a nephelometer (BN II, Dade Behring) (21).  
Measurement of IMT 
High-resolution B-mode ultrasonography was conducted in all participants ≥45 years seen during a 17-
week period (n = 496) as well as in a randomly selected sample (18%, n = 57) of participants aged 35–
44 years. We restricted this exam to older participants because they were more likely to have 
atherosclerosis and to a small randomly selected sample of younger persons (21) to limit the number 
of ultrasound exams in view of the availability of only one ultrasound examiner. Of these 553 
participants, 497 were of African or mixed descent and 491 had hs-CRP measured and were 
considered in the analysis. All ultrasound exams were performed by the same investigator, blinded to 
the risk factor status of the participants, as described previously (19). Briefly, we used a portable 
ultrasound system (GE LogiqBook) connected with a 6–10 MHz linear array transducer and coupled 
with a software (M'ATH, ICN-metric, Paris, France) performing semi-automatic measures of IMT on 
frame. IMT was measured on the far wall of the right and left common carotid arteries over a length of 
1 cm on a reference site located 2 cm below the bifurcation (22). The measurements on the left and 
right arteries were averaged to obtain a single mean value. Reproducibility of IMT measurements was 
assessed in 20 randomly selected participants re-examined within a few weeks interval: the coefficient 
of variation was 4.8%, which is consistent with other studies (23).  
Statistics 
Of the 1565 eligible participants aged 25-64, 1255 (80.2%) completed the clinical visit. Since hs-CRP 
differs between different ethnic groups (24;25) we restricted all analyses to persons categorized as 
being of predominantly African descent (n=1155), i.e. we excluded persons of predominantly 
Caucasian, Indian or Asian descent, respectively 50, 32, and 18 participants. Among these 1155 
participants, 1011 had no missing data for all considered covariates and were considered in the 
analyses. The small number of participants of non African descent precludes inter-ethnic comparison 
in this study. 
We estimated the Spearman correlation coefficients between the variables of interest and hs-CRP. We 
further examined the association between hs-CRP and risk factors using linear regression adjusted for 
age and sex. Serum hs-CRP and triglycerides were log–transformed, because of positively skewed 
distributions. For the log transformation, undetectable hs-CRP values (n=14) were recorded as 0.05 
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mg/dl since the assay could detect levels as low as 0.1 mg/dl. Sensitivity analysis showed that 
regression estimates did not differ substantially when using models where missing hs-CRP data were 
coded as 0.05 or coded as missing. We used an interaction term between sex and age in multivariate 
analyses because hs-CRP was associated with age in men but not in women. We also used an 
interaction term between sex and age for their effect on IMT. There were no significant interaction 
between sex and microalbuminuria for their effect on log hs-CRP as well as between log hs-CRP and 
sex or between log hs-CRP and cystatin C for their effect on IMT. We selected a parsimonious 
multivariate model of “independent” variables associated with hs-CRP by using stepwise multiple 
regression. For each variable included in the linear regression model, we also gave the variance (i.e. 
the proportion of the observed variation in hs-CRP explained by the variable of interest). For the age- 
and sex-adjusted models, the variance was calculated as the difference between the coefficient of 
determination of the model adjusted for age, sex and variable of interest and the coefficient of 
determination of the model adjusted for age and sex only (the variance for age and sex was 7.5%). For 
the stepwise multiple regression models, the variance was calculated as the difference between the 
coefficient of determination of the model adjusted for all variables (R2=23.1%) minus the coefficient 
of determination of the model adjusted for all variables except the variable of interest (the variance for 
age and sex was 2.4%). Similarly, we calculated the variance for the linear regression models with 
IMT (the variance for age and sex was 20.7% and the coefficient of determination of the model 
adjusted for all variables was 27.3%). 
All P-values are two-sided and values less than 0.05 were considered significant. Analyses were 
performed using Stata 11.1 software (Stata Corp., College Station, Texas, USA). 
 
 
Results 
 
Table 1 shows the baseline characteristics of the study population and the distribution of the CVRF, 
renal markers and IMT stratified by sex (26).  
Figure 1 shows that the distribution of hs-CRP was shifted to higher values in women than in men 
(our data do not include persons from Caucasian, Indian, Asian descent). Mean and median hs-CRP 
levels (mg/l) were 3.1 (SD 7.6) and 1.4 (IQR 0.7-2.9) in men and 4.5 (SD 6.7) and 2.2 (IQR 1.0-5.4) in 
women (p <0.001 for tests of both the median and the mean). Mean log hs-CRP was 0.3 (SD 1.2) in 
men and 0.8 (SD 1.2) in women.  
Association between hs-CRP and cardiovascular risk factors 
Table 2 shows that most of the considered CVRF were associated with hs-CRP. The largest Spearman 
correlation coefficients were found for indicators of adiposity, i.e. BMI, waist, and fat mass 
(approximately 0.3).  
Table 3 shows the associations between log hs-CRP and CVRF. We used standardized regression 
coefficients to enable direct comparison of the magnitude of the regression coefficients of the different 
markers. The standard regression coefficient indicates the change in log hs-CRP associated with one 
standard deviation of the explanatory variable. Consistent with findings for the Spearman correlation 
Rossi IA, Bochud M, Viswanathan B, Riesen W, Bovet P. Relation between high-sensitivity C-reactive protein and 
cardiovascular and renal markers in a middle-income country in the African region. Int J Cardiol. 2012;156(2):203-8. 
6 
 
coefficients (Table 2), the regression coefficients (and the proportion of variance explained by the 
corresponding risk factors) were largest for the adiposity markers (BMI, waist and fat mass). Alcohol 
intake and occupation were not associated with log hs-CRP while smoking was only marginally 
associated with log hs-CRP. 
Association between hs-CRP and renal markers 
Table 2 shows that cystatin C was strongly associated with hs-CRP but creatinine was not. These 
findings are confirmed by the linear regression, which shows that hs-CRP is associated with cystatin, 
uric acid and microalbuminuria but not with creatinine (Table 3).  
Association between hs-CRP, cardiovascular risk factors and renal markers using stepwise 
linear regression 
We used an automated variable selection method (i.e. stepwise linear regression) to define a 
model where all variables retained in the final model are significantly associated with the 
outcome (p-value <0.05). This parsimonious multivariate model included cigarette smoking, 
waist, fat (%), HDL cholesterol, diabetes, cystatin C, age and sex. When waist was replaced 
by BMI or by body fat (i.e. only one adiposity marker was considered at a time), adjusting for 
the same other covariates, the regression coefficient was of similar magnitude for BMI, waist 
and body fat. A multivariate model including only waist (or BMI or body fat), cystatin C and 
smoking gathered a variance (R2= ~22.4%) almost as high as the full model. 
Association between hs-CRP and IMT 
In univariate and multivariate analyses (adjusted for the considered conventional CVRF) to examine 
the association between hs-CRP and IMT, we found that several conventional CVFR but not hs-CRP 
were associated with IMT (Table 4). Of note, these analyses are based on a smaller number of 
participants and have therefore lower statistical power to detect associations. 
 
 
Discussion 
 
In this population-based survey in the African region we found that the distribution of the serum hs-
CRP concentration clearly differs according to sex, with women having higher values than men, 
independent of adiposity markers. We also found that hs-CRP concentration was associated with 
several CVRF and renal function markers, particularly cystatin C. The associations in this population 
in the African region are similar to those reported in America and Europe.  
The gender difference in the hs-CRP distribution in the Seychelles is consistent with findings across 
different ethnic groups in North America and Europe (1;24;27-29). In particular, the proportion of men 
and women with high hs-CRP values (>10 mg/l) is similar in the Seychelles and in African Americans 
(27;29). Consistent with findings in other populations (27), the higher hs-CRP values in women than 
in men remained after adjustment for adiposity markers and other potentially confounding variables. It 
has been suggested that the gender difference in hs-CRP may relate to a larger impact of adiposity in 
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inflammation in women than in men (24;30), and a sex-specific role of leptin (an adipose derived 
hormone involved in energy balance) has been suggested (31). 
Our study also shows strong associations between hs-CRP and several cardiovascular risk factors. 
Similar associations were found in Europe and North America (1;32;33). The particularly strong 
association between adiposity and hs-CRP in our study is consistent with findings in other populations 
(2;3;32-35). It has been suggested that the association between hs-CRP and adiposity reflects the 
production and release of pro-inflammatory cytokines, such as interleukin-6, interleukin-1 and tumor 
necrosis factor-α, by the adipose tissue (36) and by adipocytes themselves (37).  
With regards to renal markers, we found that hs-CRP was strongly associated with cystatin C, 
moderately associated with microalbuminuria, but no relation was found with serum creatinine. 
Although not often reported in the literature, the association between hs-CRP and cystatin C has also 
been found in a few studies in America and Europe (38-40). Cystatin C seems to be a more sensitive 
marker of kidney function than creatinine (41), and its value in the prediction of acute kidney injury 
has been demonstrated in a recent meta-analysis (42). The stronger relation between hs-CRP and 
cystatin C than between hs-CRP and creatinine may suggest that hs-CRP could reflect minimal 
reduction in renal function, which is itself associated with a worse prognosis of kidney failure (43). In 
a cross-sectional community-based study in African Americans, hs-CRP was associated with chronic 
kidney disease (independently of other CVRF) (44), and this association has also be found in 
Caucasians (45). 
In our study, hs-CRP was not associated with carotid IMT, which is often used as a proxy for 
cardiovascular outcome. A recent systematic review showed mixed results across studies. A positive 
univariate association between hs-CRP and carotid IMT was found in a majority of studies (13), but 
the association decreased or disappeared upon adjustment for CVRF. The fairly small sample size for 
IMT analysis in our study (n=491) underlies limited power to detect a relationship and our findings 
should be replicated in larger population studies in Africa. 
Strengths of the study include the population-based design, the high participation rate, and the broad 
array of measured CVRF and renal markers. Limitations include the facts that no information was 
recorded on current infections and the use of anti-inflammatory drugs, hormone replacement therapy 
and statins, which may alter hs-CRP concentration. However, these conditions are likely uncommon in 
mostly healthy participants to a population survey. hs-CRP was measured once, which is typical of 
population-based epidemiological surveys, whereas clinical guidelines recommend measurements on 
two separate days (46).  
In conclusion, the results of the distribution of hs-CRP and the association with a broad panel of 
CVRF and renal markers in a population-based study in the African region extend previous knowledge 
gained in Europe and in North America. The strong association between hs-CRP and cystatin C, a 
finding not often reported so far, is consistent with the association between hs-CRP and impaired renal 
function, although the underlying mechanisms and implications are not yet fully understood. There is 
much debate on the usefulness of hs-CRP  in clinical practice (46-49). Our study suggests that clinical 
significance of hs-CRP does not differ in sub Saharan Africa as compared to other populations. 
Rossi IA, Bochud M, Viswanathan B, Riesen W, Bovet P. Relation between high-sensitivity C-reactive protein and 
cardiovascular and renal markers in a middle-income country in the African region. Int J Cardiol. 2012;156(2):203-8. 
8 
 
Further evaluation and guidelines will be needed to guide the use of hs-CRP in clinical practice in the 
African region.  
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Table 1. Baseline characteristics of the study population according to sex  
        Men   Women   Total 
         
N    465  546  1011 
Age  mean (SD)  45.1 (10.8)  44.9 (11.1)  45.0 (11.0) 
Occupation          
Intermediate/professional  %  71.0  50.2  59.7 
Labourer  %  29.0  49.8  40.3 
Daily cigarette smoker   %  31.4  3.1  14.1 
Alcohol intake (g/day)         
0  %  37.9  82.1  61.7 
1-29.9  %  22.2  14.0  17.7 
30-59.9  %  20.2  2.8  10.8 
≥60   %  19.8  1.3  9.8 
hs-CRP (mg/l)  mean (SD)  3.1 (7.6)  4.5 (6.7)  3.9 (7.4) 
  median  1.4  2.2  1.8 
Anthropometric measures         
Body mass index (kg/m2)  mean (SD)  25.9 (4.8)  28.7 (6.1)  27.4 (5.7) 
Waist circumference (cm)  mean (SD)  90.3 (12.2)  91.5 (14.0)  91.0 (13.2) 
Fat (%)  mean (SD)  19.6 (6.7)  33.8 (7.2)  27.3 (9.9) 
Cardiovascular risk factors         
Systolic BP (mmHg)  mean (SD)  134.1 (19.0)  127.7 (20.2)  130.6 (19.8) 
Diastolic BP (mmHg)  mean (SD)  87.4 (12.1)  82.6 (12.0)  84.8 (12.3) 
LDL cholesterol (mmol/l)  mean (SD)  3.5 (1.2)  3.7 (1.2)  3.6 (1.2) 
Apoprotein B (g/l)  mean (SD)  1.1 (0.4)  1.1 (0.3)  1.1 (0.3) 
HDL cholesterol (mmol/l)  mean (SD)  1.4 (0.5)  1.4 ( 0.4)  1.4 (0.5) 
Apoprotein A1 (g/l)  mean (SD)  1.6 (0.4)  1.5 (0.3)  1.5 (0.4) 
Triglycerides (mmol/l)  median  0.9  0.8  0.9 
Insulin (µmol/l)  median  10.7  12.3  11.6 
Diabetes (yes)  %  14.4  15.0  14.7 
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Renal markers         
Creatinin (µmol/l)  mean (SD)  92.6 (20.1)  73.4 (12.6)  82.2 (19.0) 
Cystatin C (mg/l)  mean (SD)  0.9 (0.2)  0.8 (0.2)  0.8 (0.2) 
Uric acid (µmol/l)  mean (SD)  407.3 (92.5)  298.2 (81.6)  348.4 (102.4) 
Microalbuminuria (yes)  %  14.0  14.7  14.3 
IMT         
N    220  271  491 
IMT (mm)  mean (SD)  0.7 (0.1)  0.7 (0.1)  0.7 (0.1) 
 
Results are presented as percentage (prevalence), mean or median.  
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Table 2. Spearman’s correlations coefficients between hs-CRP and conventional cardiovascular risk 
factors and other characteristics (n=1011) 
 
    Men   Women 
    Coefficient P   Coefficient P 
       
Anthropometric measures       
Body mass index (kg/m2)  0.25 <0.001  0.38 <0.001 
Waist circumference (cm)  0.34 <0.001  0.38 <0.001 
Fat (%)  0.34 <0.001  0.37 <0.001 
Cardiovascular risk factors       
Systolic BP (mmHg)  0.20 <0.001  0.09 0.02 
Diastolic BP (mmHg)  0.20 <0.001  0.08 0.05 
LDL cholesterol (mmol/l)  0.15 <0.001  0.09 0.02 
Apoprotein B (g/l)  0.21 <0.001  0.15 <0.001 
HDL cholesterol (mmol/l)  0.19 <0.001  0.18 <0.001 
Apoprotein A1 (g/l)  -0.15 <0.001  -0.10 <0.001 
Triglycerides (mmol/l)  0.27 <0.001  0.26 <0.001 
Insulin (µmol/l)  0.22 <0.001  0.30 <0.001 
Glucose (mmol/l)  0.22 <0.001  0.18 <0.001 
Renal markers       
Creatinin (µmol/l)  0.04 0.30  0.05 0.17 
Cystatin C (mg/l)  0.19 <0.001  0.24 <0.001 
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Table 3. Association between log hs-CRP and conventional cardiovascular risk factors and other 
characteristics (n=1011) 
 Age- and sex-adjusted  Stepwise multivariate  
  β1 P 
Variance 
(%)    β1 P 
Variance 
(%)  
Sex     0.70 <0.001  
Age (year)     -0.16 <0.001  
Sex*age     0.62 <0.001  
Occupation2 0.01 NS 0.0     
Smoking 0.07 0.045 0.4  0.10 0.001 0.8 
Alcohol intake (g/day)   0.4     
129.9  -0.03 NS      
30-59.9  0.004 NS      
≥60  0.03 NS      
Anthropometric measures        
Body mass index (kg/m2) 0.35 <0.001 10.8     
Waist (cm) 0.38 <0.001 12.5  0.24 <0.001 2.1 
Fat (%) 0.47 <0.001 9.5  0.18 0.003 0.7 
Cardiovascular risk factors        
Systolic BP (mmHg) 0.12 <0.001 1.2     
Diastolic BP (mmHg) 0.12 <0.001 1.1     
LDL cholesterol (mmol/l) 0.11 <0.001 1.3     
Apoprotein B (g/l) 0.16 <0.001 2.4     
HDL cholesterol (mmol/l) -0.18 <0.001 3.3  -0.07 0.02 1.0 
Apoprotein A1 (g/l) -0.10 0.001 1.0     
Triglycerides (mmol/l) 0.24 <0.001 5.3     
Insulin (µmol/l) 0.21 <0.001 4.5     
Diabetes (yes/no) 0.15 <0.001 2.1  0.09 0.002 0.7 
Renal markers        
Creatinin (µmol/l) 0.04 NS 0.1     
Cystatin C (mg/l) 0.19 <0.001 3.3  0.15 <0.001 2.2 
Uric acid (µmol/l) 0.21 <0.001 3.0     
Microalbuminuria (yes/no) 0.14 <0.001 1.8     
 
1β = standardized linear regression coefficient 
2Occupation is “laborer” category compared to “intermediate/professionals” categories.
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Table 4. Association between hs-CRP and carotid intima-media thickness (IMT)  
 Age- and sex-adjusted  Multiple linear regression1  
  Β2 P Variance   Β2 P Variance 
Log hs-CRP (mg/l) 0.03 ns 0.10  -0.04 ns 0.10 
Smoking -0.05 ns -0.47  -0.01 ns 0.01 
BMI (kg/m2) 0.12 0.005 1.26  0.06 ns 0.23 
Systolic BP (mmHg) 0.14 0.002 1.60  0.1 0.02 0.81 
LDL cholesterol (mmol/l) 0.15 <0.001 1.55  0.12 0.005 1.19 
HDL cholesterol (mmol/l) -0.16 <0.001 2.51  -0.1 0.02 0.89 
Diabetes  0.14 0.001 1.72  0.09 0.03 0.73 
1Adjusted for smoking, BMI, systolic BP, LDL and HDL cholesterol and diabetes 
2β = standardized regression coefficient 
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Figure 1. Cumulative distribution of serum hs-CRP in men and women (range 0-10 mg/l) 
 
 
 
